Arthur G Cook,
ZS Associates, USA
Title: The Commercial Landscape for Biosimilars: Planning in an Uncertain Environment
Biography
Biography: Arthur G Cook,
Abstract
Over the next 10 years $71 billion in worldwide biopharmaceutical revenue may be affected by the launch of biosimilar products. Several biosimilar launchs already have taken place in multiple countries, and observations from uptake in these markets hold insight for strategic planners. In countries such as the US the commercial landscape is complicated by additional uncertainties in regulatory and legal policy. In this talk we will examine the learnings from prior lauches and apply these insights in a decision analysis framework to aid in planning for future biosimilar introductions